More importantly, the hazard ratio for major adverse cardiovascular events (including cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina) for the pooled tirzepatide groups versus glargine was 0.74 (95% CI 0.511.08), suggesting no increased cardiovascular risk with tirzepatide compared to insulin glargine
An important limitation of the available evidence is the relatively short duration of follow-up in many included trials
During these trials, a judge will examine information provided by expert witnesses for the plaintiffs and defendants
And although side effects can occur when taking GLP1 drops , their frequency and severity are usually low
and doing so could cause the levels to build up and cause more frequent side effects
Hypoglycemia and cardiovascular risk: is there a major link